Skip to main content

Advertisement

Log in

Outcomes of robotic esophagectomies for esophageal cancer by hospital volume: an analysis of the national cancer database

  • 2020 SAGES Oral
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Robotic minimally invasive esophagectomies (RMIE) have been associated with superior outcomes; however, it is unclear if these are specific to robotic technique or are present only at high-volume institutions. We hypothesize that low-volume RMIE centers would have inferior outcomes.

Methods

The National Cancer Database (NCDB) identified patients receiving RMIE from 2010 to 2016. Based on the total number of RMIE performed by each hospital system, the lowest quartile performed ≤ 9 RMIE over the study period. Ninety-day mortality, number of lymph nodes evaluated, margins status, unplanned readmissions, length of stay (LOS), and overall survival were compared. Regression models were used to account for confounding.

Results

1565 robotic esophagectomies were performed by 212 institutions. 173 hospitals performed ≤ 9 RMIE (totaling 478 operations over the study period, 30.5% of RMIE) and 39 hospitals performed > 9 RMIE (1087 operations, 69.5%). Hospitals performing > 9 RMIE were more likely to be academic centers (90.4% vs 66.2%, p < 0.001), have patients with advanced tumor stage (65.3% vs 59.8%, p = 0.049), andadministered preoperative radiation (72.8% vs 66.3%, p = 0.010). There were no differences based on demographics, nodal stage, or usage of preoperative chemotherapy. On multivariable regressions, hospitals performing ≤ 9 RMIE were associated with a greater likelihood of experiencing a 90-day mortality, a reduced number of lymph nodes evaluated, and a longer LOS; however, there was no association with rates of positive margins or unplanned readmissions. Median overall survival was decreased at institutions performing ≤ 9 RMIE (37.3 vs 51.5 months, p < 0.001). Multivariable Cox regression demonstrated an association with poor survival comparing hospitals performing ≤ 9 to > 9 RMIE (HR 1.327, p = 0.018).

Conclusion

Many robotic esophagectomies occur at institutions which performed relatively few RMIE and were associated with inferior short- and long-term outcomes. These data argue for regionalization of robotic esophagectomies or enhanced training in lower volume hospitals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2020) Cancer Statistics, 2020. CA Cancer J Clin 70:7–30

    Google Scholar 

  2. Key Statistics for Esophageal Cancer. American Cancer society. https://www.cancer.org/cancer/esophagus-cancer/about/key-statistics.html. Accessed 19 Mar 2020

  3. Altorki N, Harrison S (2017) What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer? Ann Cardiothorac Surg 6:167–174

    Article  Google Scholar 

  4. Sihag S, Kosinski AS, Gaissert HA, Wright CD, Schipper PH (2016) Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from the society of thoracic surgeons national database. Ann Thorac Surg 101:1281–1289

    Article  Google Scholar 

  5. Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256:95–103

    Article  Google Scholar 

  6. van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA, Kroese CC, Haj Mohammad N, Mook S, Vleggaar FP, Borel Rinkes IHM, Ruurda JP, van Hillegersberg R (2019) Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 269:621–630

    Article  Google Scholar 

  7. Yerokun BA, Sun Z, Yang CJ, Gulack BC, Speicher PJ, Adam MA, D'Amico TA, Onaitis MW, Harpole DH, Berry MF, Hartwig MG (2016) Minimally invasive versus open esophagectomy for esophageal cancer: a population-based analysis. Ann Thorac Surg 102:416–423

    Article  Google Scholar 

  8. Rolff HC, Ambrus RB, Belmouhand M, Achiam MP, Wegmann M, Siemsen M, Kofoed SC, Svendsen LB (2017) Robot-assisted hybrid esophagectomy is associated with a shorter length of stay compared to conventional transthoracic esophagectomy: a retrospective study. MIS. https://doi.org/10.1155/2017/6907896

    Article  PubMed  Google Scholar 

  9. Jin D, Yao L, Yu J, Liu R, Guo T, Yang K, Guo Y (2019) Robotic-assisted minimally invasive esophagectomy versus the conventional minimally invasive one: a meta-analysis and systematic review. Int J Med Robot 15:e1988

    Article  Google Scholar 

  10. Salfity H, Timsina L, Su K, Ceppa DK, Birdas T (2019) Case Volume-to-outcome relationship in minimally invasive esophagogastrectomy. Ann Thoraic Surg 108:1491–1497

    Article  Google Scholar 

  11. The National Cancer Database 2016 PUF Data Dictionary. American College of Surgeons. https://ncdbpuf.facs.org. Accessed 1 Apr 2020

  12. van der Sluis PC, Ruurda JP, van der Horst S, Goense L, van Hillegersberg R (2018) Learning curve for robot-assisted minimally invasive thoracoscopic esophagectomy: results from 312 cases. Ann Thorac Surg 106:264–271

    Article  Google Scholar 

  13. Zhang H, Chen L, Wang Z, Zheng Y, Geng Y, Wang F, Liu D, He A, Ma L, Yuan Y, Wang Y (2018) The learning curve for robotic mckeown esophagectomy in patients with esophageal cancer. Ann Thorac Surg 105:1024–1030

    Article  Google Scholar 

  14. Hernandez JM, Dimou F, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, Meredith K (2013) Defining the learning curve for robotic-assisted esophagogastrectomy. J Gastrointest Surg 17:1346–1351

    Article  Google Scholar 

  15. de la Fuente SG, Weber J, Hoffe SE, Shridhar R, Karl R, Meredith KL (2013) Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes. Surg Endosc 27:3339–3347

    Article  Google Scholar 

  16. Okusanya OT, Hess NR, Luketich JD, Sarkaria IS (2017) Technique of robotic assisted minimally invasive esophagectomy (RAMIE). J Vis Surg 3:116

    Article  Google Scholar 

  17. Fuchs HF, Müller DT, Leers JM, Schröder W, Bruns CJ (2019) Modular step-up approach to robot-assisted transthoracic esophagectomy-experience of a German high volume center. Transl Gastroenterol Hepatol. https://doi.org/10.21037/tgh.2019.07.04

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wright JD, Tergas AI, Hou JY, Burke WM, Chen L, Hu JC, Neugut AI, Ananth CV, Hershman DL (2016) Effect of regional hospital competition and hospital financial status on the use of robotic-assisted surgery. JAMA Surg 151:612–620

    Article  Google Scholar 

  19. Esophageal and esophagogastric junction cancers, Version 1. (2014) National comprehensive cancer network guidelines. https://www.spg.pt/wp-content/uploads/Guidelines/NCCN/esophageal.pdf. Accessed 19 Mar 2020

  20. Groth SS, Virnig BA, Whitson BA, DeFor TE, Li ZZ, Tuttle TM, Maddaus MA (2010) Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg 139:612–620

    Article  Google Scholar 

  21. Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M (2008) Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248:221–226

    Article  Google Scholar 

  22. Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251:46–50

    Article  Google Scholar 

  23. Worrell SG (2020) Esophageal cancer and surgical margins: when a positive is a negative. Ann Surg Oncol. https://doi.org/10.1245/s10434-019-08181-2

    Article  PubMed  Google Scholar 

  24. van der Schaaf M, Johar A, Wijnhoven B, Lagergren P, Lagergren J (2015) Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst 248:549–556

    Google Scholar 

  25. Lagergren J, Mattsson F, Zylstra J, Chang F, Gossage J, Mason R, Lagergren P, Davies A (2016) Extent of lymphadenectomy and prognosis after esophageal cancer surgery. JAMA Surg 151:32–39

    Article  Google Scholar 

  26. Schlick CJR, Khorfan R, Odell DD, Merkow RP, Bentrem DJ (2020) Margin positivity in resectable esophageal cancer: are there modifiable risk factors? Ann Surg Oncol 27:1496–1507

    Article  Google Scholar 

  27. Javidfar J, Speicher PJ, Hartwig MG, D’Amico TA, Berry MF (2019) Impact of positive margins on survival in patients undergoing esophagogastrectomy for esophageal cancer. Ann Thorac Surg 101:1060–1067

    Article  Google Scholar 

  28. Giwa F, Salami A, Abiove AI (2018) Hospital esophagectomy volume and postoperative length of stay: a systematic review and meta-analysis. Am J Surg 215:155–162

    Article  Google Scholar 

  29. Ely S, Alabaster A, Ashiku SK, Patel A, Velotta JB (2019) Regionalization of thoracic surgery improves short-term cancer esophagectomy outcomes. J Thorac Dis 11:1867–1878

    Article  Google Scholar 

  30. Ma L, Li J, Shao L, Lin D, Xiang J (2015) Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer. J Thorac Dis 7:2018–2023

    PubMed  PubMed Central  Google Scholar 

  31. Freeman WJ, Weiss AJ, Heslin KC (2018) Overview of U.S. hospital stays in 2016: variation by geographic region. HCUP statistical brief #246. www.hcup-us.ahrq.gov/reports/statbriefs/sb246-Geographic-Variation-Hospital-Stays.pdf. Accessed 2 Apr 2020

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher W. Towe.

Ethics declarations

Disclosures

Christopher W. Towe discloses that he is a consultant to Sig Medical, Zimmer Biomet, Medtronic, and Atricure, but that these relationships have not influenced the work or its conclusions. Jonathan J. Hue, Katelynn C. Bachman, Stephanie G. Worrell, Kelsey E. Gray and Philip A. Linden have no conflicts of interest or financial ties to disclose. The other authors have no disclaimers, sources of funding, or financial relationships that could inappropriately influence this work and its conclusions.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hue, J.J., Bachman, K.C., Worrell, S.G. et al. Outcomes of robotic esophagectomies for esophageal cancer by hospital volume: an analysis of the national cancer database. Surg Endosc 35, 3802–3810 (2021). https://doi.org/10.1007/s00464-020-07875-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-07875-z

Keywords

Navigation